When to Combine Endocrine Therapy With a New Agent for Hormone Receptor-Positive Metastatic Breast Cancer in Postmenopausal Women

被引：0

作者：

Seidman, Andrew D. ^{[1
,2
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[2] Weill Cornell Med Coll, New York, NY USA

来源：

ONCOLOGY-NEW YORK | 2016年 / 30卷 / 03期

关键词：

MONOTHERAPY; PALBOCICLIB;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：224 / 228

页数：5

共 50 条

[1] What Is the Optimal Endocrine Therapy for Postmenopausal Women With Hormone Receptor-Positive Early Breast Cancer?
Tung, Nadine
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (11) : 1391 - 1397
[2] Adjuvant Endocrine Therapy of Perimenopausal and Recently Postmenopausal Women With Hormone Receptor-Positive Breast Cancer
Pan, Kathy
Chlebowski, Rowan T.
CLINICAL BREAST CANCER, 2014, 14 (03) : 147 - 153
[3] Endocrine therapy combined with targeted therapy in hormone receptor-positive metastatic breast cancer
Bian Li
Xu Feng-Rui
Jiang Ze-Fei
中华医学杂志英文版, 2020, 133 (19) : 2338 - 2345
[4] Endocrine therapy combined with targeted therapy in hormone receptor-positive metastatic breast cancer
Bian, Li
Xu, Feng-Rui
Jiang, Ze-Fei
CHINESE MEDICAL JOURNAL, 2020, 133 (19) : 2338 - 2345
[5] Endocrine Therapy in the Current Management of Postmenopausal Estrogen Receptor-Positive Metastatic Breast Cancer
Kaklamani, Virginia G.
Gradishar, William J.
ONCOLOGIST, 2017, 22 (05): : 507 - 517
[6] Neoadjuvant endocrine therapy for postmenopausal patients with hormone receptor-positive early breast cancer: a new concept
Hiroji Iwata
Breast Cancer, 2011, 18 : 92 - 97
[7] Neoadjuvant endocrine therapy for postmenopausal patients with hormone receptor-positive early breast cancer: a new concept
Iwata, Hiroji
BREAST CANCER, 2011, 18 (02) : 92 - 97
[8] Endocrine Therapy in Premenopausal Hormone Receptor-Positive Breast Cancer
Tevaarwerk, Amye J.
Wisinski, Kari B.
O'Regan, Ruth M.
JOURNAL OF ONCOLOGY PRACTICE, 2016, 12 (11) : 1148 - +
[9] LapatinibIn Postmenopausal Women with Hormone Receptor-Positive, HER2-Positive Metastatic Breast Cancer
Monique P. Curran
Drugs, 2010, 70 : 1411 - 1422
[10] Lapatinib In Postmenopausal Women with Hormone Receptor-Positive, HER2-Positive Metastatic Breast Cancer
Curran, Monique P.
DRUGS, 2010, 70 (11) : 1411 - 1422

← 1 2 3 4 5 →